Iranian journal of Pediatric Hematology and Oncology
Iranian journal of Pediatric Hematology and Oncology
Iran J Ped Hematol Oncol
Medical Sciences
http://ijpho.ssu.ac.ir
1
admin
2008-8892
2228-6993
8
7
14
8888
13
en
jalali
1389
8
1
gregorian
2010
11
1
1
1
online
1
fulltext
en
Sequential Deferoxamine - Deferasirox in Treatment of Major Thalassemia with Iron Overload
قلب
Heart
پژوهشي
Research
Abstract
Background
Iron overload is a major problem in patients with major thalassemia. An effective and safe iron chelator protocol with high compliance rate plays an important role in treatment of these patients. This study was done to assess the efficacy and safety of the sequential deferoxamine and deferasirox protocol in major thalassemia patients in Khuzestan province, Iran.
Material and Method
Sixty two patients were studied aged between 2 to 30 years old. A regimen consisted of 4 days deferasirox followed by 3 days deferoxamine. The duration of trial was 6 months. The efficacy was determined by comparison of ferritin level before and after treatment.
Results
Serum ferritin changed from 3590 ng/ml to 2563 ng /ml, which decreased significantly. During study 21% of patients experienced at least one side effect.
Conclusion
This is a new regimen with high efficacy, low toxicity and acceptable compliance.
Sequential, Deferoxamine, Deferasirox, Major thalassemia.
14
18
http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-1-4&slc_lang=en&sid=1
Bijan
Keikhaei
Yes